[ Clinical study of the efficacy of and tolerance to <font color="red">nimesulide_4</font> in suppository formulation in pain - inflammatory pathologies of the ear , nose , and throat ] . 
<br>
<br> The efficacy and tolerability of a new pharmaceutical form of the non - steroid anti - inflammatory drug . <font color="red">Nimesulide_5</font> have been studied in a double blind study compared with <font color="red">flurbiprofen_5</font> <font color="red">,_5</font> in 98 patients aged between 18 and 75 suffering from pain - inflammatory pathologies of ENT nature . Both drugs , administered in a dose of one suppository twice a day for 7 days , showed marked anti - inflammatory , analgesic and antipyretic activity and produced a significant , progressive improvement in the typical symptoms of the inflammatory state up to their complete remission . <font color="red">Nimesulide_3</font> evidenced greater speed and duration of therapeutic action . Assessment on the effectiveness and tolerability as expressed separately by the physician and patient were positive in almost all cases of both treatments .